Literature DB >> 11956879

Nephrocalcinosis in preterm infants: a single center experience.

Bernd Hoppe1, Ibrahim Duran, Alexa Martin, Angela Kribs, Gabriele Benz-Bohm, Dietrich V Michalk, Bernhard Roth.   

Abstract

The risk of nephrocalcinosis in preterm infants is considerable, but conflicting numbers are given for the actual incidence (10-65%). Furosemide induced hypercalciuria is said to be the main risk factor. We examined retrospectively the incidence, causes and outcome of nephrocalcinosis in preterm infants born in our hospital from 1988 to 1998 ( n=2190). An abnormal renal echogenicity or nephrocalcinosis was seen in 31 infants (29.7+/-3.3 weeks gestational age; 1307+/-690 g birth weight). Nephrocalcinosis was diagnosed in 16, hyperechoic kidneys (HK) in 10 and Tamm-Horsfall kidneys in 5 infants. Main risk factors were low gestation age and birth weight, length of hospitalization, variations in acid-base status, length of assistant ventilation and hypercalciuria at diagnosis. The incidence of nephrocalcinosis was 0.73% [1.7% for low birth weight infants (VLBW)]. Taking the cases of nephrocalcinosis and HK together, incidence was calculated to be 1.2% overall and 2.5% for VLBW infants, but increased to 7% in 1998. The follow-up showed persisting nephrocalcinosis or hyperechoic kidneys in 8/26 preterm infants. In conclusion, the incidence of nephrocalcinosis was lower in our population than is usually reported. The numbers have, however, increased over the past few years. From the follow-up it was obvious that long-term observation of preterm infants is necessary and that complications might arise in the long run.

Entities:  

Mesh:

Year:  2002        PMID: 11956879     DOI: 10.1007/s00467-001-0816-8

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  17 in total

Review 1.  Diuretics in pediatrics : current knowledge and future prospects.

Authors:  Maria M J van der Vorst; Joana E Kist; Albert J van der Heijden; Jacobus Burggraaf
Journal:  Paediatr Drugs       Date:  2006       Impact factor: 3.022

2.  Renal function and kidney length in preterm infants with nephrocalcinosis: a longitudinal study.

Authors:  Vasileios Giapros; Constantina Tsoni; Anna Challa; Vasileios Cholevas; Maria Argyropoulou; Frederica Papadopoulou; Ekaterini Siomou; Aikaterini Drougia; Styliani Andronikou
Journal:  Pediatr Nephrol       Date:  2011-05-01       Impact factor: 3.714

3.  Neonatal nephrocalcinosis: long term follow up.

Authors:  E Porter; A McKie; T J Beattie; J H McColl; N Aladangady; A Watt; M P White
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2006-05-16       Impact factor: 5.747

Review 4.  Drug-Induced Urolithiasis in Pediatric Patients.

Authors:  Maria Chiara Sighinolfi; Ahmed Eissa; Luigi Bevilacqua; Ahmed Zoeir; Silvia Ciarlariello; Elena Morini; Stefano Puliatti; Viviana Durante; Pier Luca Ceccarelli; Salvatore Micali; Giampaolo Bianchi; Bernardo Rocco
Journal:  Paediatr Drugs       Date:  2019-10       Impact factor: 3.022

5.  Development of nephrocalcinosis in very low birth weight infants.

Authors:  Guido Hein; Detlef Richter; Friedrich Manz; Dieter Weitzel; Hermann Kalhoff
Journal:  Pediatr Nephrol       Date:  2004-03-31       Impact factor: 3.714

6.  Urinary excretion of calcium and phosphate in preterm infants.

Authors:  Narendra Aladangady; Pietro G Coen; Madeleine P White; Margaret D Rae; T James Beattie
Journal:  Pediatr Nephrol       Date:  2004-11       Impact factor: 3.714

7.  Reversible renal medullary hyperechogenicity in neonatal hypernatremic dehydration.

Authors:  Uma Sankari Ali; Kalpana Sengupta; Parmanand Andankar; Sandeep Saraf; Aashish Chawla; Shailendra Deshpande
Journal:  Pediatr Nephrol       Date:  2004-06-16       Impact factor: 3.714

8.  Urinary lithogenic and inhibitory factors in preterm neonates receiving either total parenteral nutrition or milk formula.

Authors:  Vasilios I Giapros; Athanasios L Papaloukas; Anna S Challa; Panagiotis D Nikolopoulos; Constantine G Tsampoulas; Styliani K Andronikou
Journal:  Eur J Pediatr       Date:  2003-05-16       Impact factor: 3.183

9.  Developmental changes of oxalate excretion in enterally fed preterm infants.

Authors:  S Illsinger; T Lücke; B Vaske; K-H Schmidt; B Bohnhorst; A M Das
Journal:  J Inherit Metab Dis       Date:  2008-12-12       Impact factor: 4.982

10.  High incidence of nephrocalcinosis in extremely preterm infants treated with dexamethasone.

Authors:  David J Cranefield; David E Odd; Jane E Harding; Rita L Teele
Journal:  Pediatr Radiol       Date:  2003-11-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.